1 February 2023
We caught up with Ercan Altınöz, Associate Professor of Psychiatry at Eskişehir Osmangazi University School of Medicine in Eskişehir, Turkey, who told us how combining CANTAB® tasks with machine learning may help to improve diagnosis of bipolar disorder.
17 January 2023
How CANTAB can be used to overcome challenges in assessing cognition in people with intellectual disabilities
Operational scientist Eleanor Rist explores how CANTAB™ assessments can be beneficial for studies involving people with intellectual disabilities.
6 January 2023
We caught up with Dr Ferenc Magyari from the University of Debrecen, who told us how CANTABTM has helped them to understand the long-term cognitive impact of Hodgkin’s Lymphoma.
5 December 2022
2022 CANTAB Research Grant: Carotenoid uptake and cognitive and visual outcomes in Ghanaian schoolchildren
We caught up with the 2022 CANTABTM Research Grant Primary Award Winner, Nana Aba Senuwah Ashon, who tells us how the grant will help to understand the role of carotenoid uptake on vision and congition in Ghanaian schoolchildren.
25 November 2022
John Bernstein, Clinical Scientist at Cambridge Cognition, explores the trends and exciting developments that were discussed at the 2022 Society for Neuroscience (SfN) conference.
23 November 2022
In June 2022 we conducted a survey to find out more about what our academic customers think of Cambridge Cognition’s products and services. These surveys are a great opportunity for our customers to give us their honest and candid feedback. We had a great response and gained some very interesting insights and feedback. Here we discuss four of the main points that we learned from the survey.
3 November 2022
This poster was presented at ECTRIMS in October 2022.